PDS Biotechnology Corporation share price logo

PDS Biotechnology Corporation

NASDAQ: PDSB

Small Cap

$0.95

+0.05

(+5.06%)

as on

PDS Biotechnology Corporation Stock Performance

as on June 19, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $0.88
    $0.93
    downward going graph

    7.37%

    Downside

    -2.11%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.51
    $1.67
    downward going graph

    46.65%

    Downside

    75.26%

    Upside

    downward going graph

PDS Biotechnology Corporation share price movements today

Previous Close
$0.91
Open
$0.92
Volume
623.7K
Day's Low - High
$0.88 - $0.93
52 Week Low - High
$0.51 - $1.67

PDS Biotechnology Corporation Historical Returns

1 Month Return
-4.5 %
3 Month Return
+ 52.78 %
1 Year Return
-40.68 %
3 Year Return
-84.16 %
5 Year Return
-91.71 %

PDS Biotechnology Corporation Stock Fundamentals & Key Indicators

Check PDS Biotechnology Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$50.7M

EPS (TTM)

-0.4967

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-28.9M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-244.16%

PDS Biotechnology Corporation vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of PDS Biotechnology Corporation with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
PDS Biotechnology Corporation image
PDS Biotechnology Corporation
BUY$50.7M-91.71%NA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$37.7B57.21%71.2112.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$116.5B140.42%27.2235.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$63.7B13.39%14.8529.65%0.58%

Stock Returns calculator for PDS Biotechnology Corporation Stock including INR - Dollar returns

The PDS Biotechnology Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

PDS Biotechnology Corporation investment value today

Current value as on today

₹64,082

Returns

-₹35,918

(-35.92%)

Returns from PDS Biotechnology Corporation Stock

-₹40,994 (-40.99%)

Dollar Impact

₹5,075 (+5.08%)

Analyst Recommendation on PDS Biotechnology Corporation Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for PDS Biotechnology Corporation. Average target price of $7.5

PDS Biotechnology Corporation Share Price Target

Get share price movements and forecasts by analysts on PDS Biotechnology Corporation.

What analysts predicted

87.33%UPSIDE

Target Price

$7.5

Current Price

$0.95

Analyzed by

12 Analysts

Target

$7.50

PDS Biotechnology Corporation target price $7.5, a slight upside of 87.33% compared to current price of $0.95. According to 12 analysts rating.

Indian Investors' Interest in PDS Biotechnology Corporation Stock

Search interest for PDS Biotechnology Corporation Stock has increased by 29% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:29% versus previous 30 day period

PDS Biotechnology Corporation Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
0
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
-
0
-
Operating Income
-10
-10
-8
-10
-7
-9
-7
-8
-6
-6
EBITDA
-9
-9
-8
-9
-6
-8
-7
-7
-6
-6
Interest Expense
1
1
1
1
1
0
2
1
1
1
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-10
-10
-9
-10
-7
-9
-9
-9
-7
-7
Income Tax Expense
0
0
0
-10,726
870
-1
-
-
2
-
Net Income
-10
-10
-8
-10
-7
-8
-9
-9
-7
-7
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-13463.50%
0.00%
0.00%
0.00%
0.00%
0.00%

PDS Biotechnology Corporation Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-39
-51
-43
-15
-14
-21
-41
-43
-36
-31
EBITDA
-39
-51
-3
-7
-14
-21
-40
-40
-33
-30
Interest Expense
1
2
1
0
0
0
1
4
4
5
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
-40
-53
-3
-7
-14
-21
-42
-44
-38
-35
Income Tax Expense
-1
-2
-2
0
0
-4
-1
-1
0
-1
Net Income
-38
-50
-40
-6
-14
-16
-40
-42
-37
-34
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

PDS Biotechnology Corporation Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-10
-8
-10
-7
-8
-9
-9
18,822
-7
Operating Cash Flow
-9
-8
-7
-8
-9
-9
-5
-3
-4,371
Investing Cash Flow
-
0
0
-28
-
-
-
-
-
Financing Cash Flow
20
0
0
0
7
0
0
4
-679
Change in Cash
10
-8
-7
-8
-1
-8
-5
0
-5,051

PDS Biotechnology Corporation Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-50
-40
-6
-14
-16
-40
-42
-37
-34,495
Operating Cash Flow
-40
-33
-18
-13
-12
-25
-33
-35
-27,752
Investing Cash Flow
0
29
29
-
-
-
-
0
-
Financing Cash Flow
22
-20
0
29
48
34
16
20
12,774
Change in Cash
-18
-53
12
16
36
8
-17
-14
-14,977

Global Institutional Holdings in PDS Biotechnology Corporation

Funds
Holdings
Watts Gwilliam and Company, LLC
0.1%
Amussen, Hunsaker & Associates Incorporated
0.13%
Susquehanna International Group, LLP
0.04%
Bank of New York Mellon Corp
0.12%
TWO SIGMA SECURITIES, LLC
0.06%
See all

PDS Biotechnology Corporation News & Key Events

  • img

    Today's Timeline - 18 September

    Thu, 06:21 PM

    -

    PDS Biotechnology reports median overall survival of 29.5 months in low PD-L1 expression cohort from VERSATILE-002 trial.

Insights on PDS Biotechnology Corporation

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, PDS Biotechnology Corporation Common Stock has experienced a drawdown of -84.0%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 62.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 19.7% return, outperforming this stock by 60.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, PDSB stock has moved down by -9.0%

About PDS Biotechnology Corporation

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States. The company's lead product candidate is PDS0101, a Versamune HPV, which is in phase II clinical trial for the treatment of head and neck, cervical, anal, vaginal, vulvar, and penile cancers. It also develops various product candidates, which are in preclinical trials, including PDS0102, an investigational immunotherapy utilizing tumor-associated and immunologically active T cell receptor gamma alternate reading framed protein for treating acute myeloid leukemia, prostate, and breast cancer; and PDS0103 for ovarian, breast, colorectal, and lung cancers. In addition, the company is developing PDS01ADC, a novel investigational Interleukin 12 fused antibody-drug conjugate, tumor-targeting interleukin 12 immune-cytokine that enhances the proliferation, potency, and longevity of T cells in the tumor microenvironment. It has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, Georgia Research Foundation, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Princeton, New Jersey.
OrganisationPDS Biotechnology Corporation
Headquarters303A College Road East, Princeton, NJ, United States, 08540
IndustryBiotechnology
CEODr. Frank K. Bedu-Addo Ph.D.
E-voting on sharesClick here to vote

Key Management of PDS Biotechnology Corporation

Name

Title

Ms. Janetta Trochimiuk

Controller

Dr. Frank K. Bedu-Addo Ph.D.

President, CEO & Director

Mr. Stephan Toutain M.B.A., M.S.

Chief Operating Officer

Dr. Kirk V. Shepard M.D.

Chief Medical Officer

Mr. Lars Robert Boesgaard M.B.A.

Principal Financial & Accounting Officer and CFO

Dr. Gregory L. Conn Ph.D.

Chief Scientific Officer

Mr. Spencer Brown J.D.

Senior VP, General Counsel, Corporate Secretary & Chief Compliance Officer

FAQs

What is PDS Biotechnology Corporation share price today?

PDS Biotechnology Corporation share price today is $0.95 as on at the close of the market. PDS Biotechnology Corporation share today touched a day high of $0.93 and a low of $0.88.

What is the 52 week high and 52 week low for PDS Biotechnology Corporation share?

PDS Biotechnology Corporation share touched a 52 week high of $1.67 on and a 52 week low of $0.51 on . PDS Biotechnology Corporation stock price today i.e. is closed at $0.95,which is 42.94% down from its 52 week high and 87.45% up from its 52 week low.

What is PDS Biotechnology Corporation's market capitalisation today?

PDS Biotechnology Corporation market capitalisation is $0.00T as on .

How to invest in PDS Biotechnology Corporation Stock (PDSB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for PDS Biotechnology Corporation on INDmoney app. Click on Buy button. You can invest as low as $1.5 in PDS Biotechnology Corporation Shares that will get you 1.5789 shares as per PDS Biotechnology Corporation share price of $0.95 per share as on June 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy PDS Biotechnology Corporation Stock (PDSB) from India?

Indian investors can start investing in PDS Biotechnology Corporation (PDSB) shares with as little as ₹94.31 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in PDS Biotechnology Corporation stock (as per the Rupee-Dollar exchange rate as on ). Based on PDS Biotechnology Corporation share’s latest price of $0.95 as on June 19, 2026 at 8:45 am IST, you will get 10.5263 shares of PDS Biotechnology Corporation. Learn more about fractional shares .

What are the returns that PDS Biotechnology Corporation has given to Indian investors in the last 5 years?

PDS Biotechnology Corporation stock has given -91.71% share price returns and 27.56% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?